Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 35,715 shares at $33.44 ($1.2M) on 2022-03-22, disclosed to the SEC on 2022-03-22.
Open-market sale of $1.2M ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.44 | 5,822 | $195K | 16.0% |
| 2 | $33.44 | 5,822 | $195K | 16.0% |
| 3 | $34.11 | 9,908 | $338K | 27.7% |
| 4 | $34.11 | 9,908 | $338K | 27.7% |
| 5 | $35.22 | 1,159 | $41K | 3.3% |
| 6 | $36.51 | 1,548 |
| $57K |
| 4.6% |
| 7 | $36.51 | 1,548 | $57K | 4.6% |
| Total | $34.14 avg | 35,715 | $1.2M | 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |
| ITOS | SELL | 2022-01-26 | $1.0M | — | Filing → |